Pursuant to Regulation 29 (1) (a) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to intimate that a meeting of the Board of Directors of the Company will be held on Saturday, December 09, 2017, at the Corporate Office of the Company to, inter alia:
i) consider and approve unaudited Stand-alone as well as Consolidated Financial Results of the Company for the quarter / half year ended September 30, 2017.
ii) consider declaration of Interim Dividend for the Financial Year 2017-18
Intimation of the above meeting of the Board of Directors is also being published in newspapers, as required under Regulation 47 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015.
Thyrocare Technologies: Board Meeting On 09-12-2017
November 27, 2017
Informed fund ideas, better judgment. Every month. Mutual Fund Insight, every month since October 2002.
Take charge. Know more. Keep more. Mutual Fund Insight helps you do all three — every month